BioRestorative Therapies (BRTX) Treasury Shares (2010 - 2023)
BioRestorative Therapies' (BRTX) quarterly Treasury Shares came in at $16875.0 in Q2 2016, down 47.27% YoY from $32000.0 in Q3 2015, and down 47.27% on a QoQ basis from $32000.0 in Q1 2016.
BioRestorative Therapies (BRTX) Treasury Shares (2010 - 2023) Analysis & Trends
BioRestorative Therapies (BRTX) has 10 years of Treasury Shares data on file, last reported at $97827.0 in Q4 2023.
- Quarterly Treasury Shares fell 47.27% year-over-year to $16875.0 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $16875.0 (down 47.27% YoY) and the FY2015 annual result came in at $32000.0, changed 0.0% from the prior year.
- Treasury Shares steadied at $97827.0 in Q4 2023, from $97827.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.2 billion in Q1 2021 to a low of $97827.0 in Q1 2023.
- A 5-year average of $31159.7 and a median of $32000.0 in 2012 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 29.1% in 2022, down 99.98% in 2022.
- Tracing BRTX's Treasury Shares over 5 years: stood at $32000.0 in 2012, then changed by 0.0% to $32000.0 in 2013, then changed by 0.0% to $32000.0 in 2014, then changed by 0.0% to $32000.0 in 2015, then plunged by 47.27% to $16875.0 in 2016.
- The last three Treasury Shares figures came in at $16875.0 (Q2 2016), $32000.0 (Q1 2016), and $32000.0 (Q4 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 97,827.00 |
| Dec 31, 2023 | 97,827.00 |
| Sep 30, 2023 | 97,827.00 |
| Sep 30, 2023 | 97,827.00 |
| Jun 30, 2023 | 97,827.00 |
| Jun 30, 2023 | 97,827.00 |
| Mar 31, 2023 | 97,827.00 |
| Mar 31, 2023 | 97,827.00 |
| Dec 31, 2022 | 201,870.00 |
| Dec 31, 2022 | 201,870.00 |
| Sep 30, 2022 | 208,086.00 |
| Sep 30, 2022 | 208,086.00 |
| Jun 30, 2022 | 214,303.00 |
| Jun 30, 2022 | 214,303.00 |
| Mar 31, 2022 | 220,527.00 |
| Mar 31, 2022 | 220,527.00 |
| Dec 31, 2021 | 293,480.00 |
| Dec 31, 2021 | 293,480.00 |
| Sep 30, 2021 | 293,479.00 |
| Sep 30, 2021 | 293,479.00 |